Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-09-12 Sale | 2025-09-15 5:39 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Chief Tech. Ops. Officer | 5,000 | $45.87 | $229,350 | 20,496 (Direct) | View |
| 2025-09-08 Sale | 2025-09-09 4:21 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 6,322 | $46.29 | $292,645 | 1,274,483 (Direct) | View |
| 2025-09-05 Sale | 2025-09-08 4:31 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 55,578 | $46.01 | $2,557,144 | 2,286,405 (Indirect Direct) | View |
| 2025-08-27 Sale | 2025-08-29 4:05 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 34,800 | $45.1 | $1,569,431 | 2,287,012 (Indirect Direct) | View |
| 2025-08-27 Sale | 2025-08-29 4:05 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 3,588 | $45.01 | $161,496 | 129,644 (Direct) | View |
| 2025-08-25 Sale | 2025-08-27 4:59 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 14,000 | $44.51 | $623,140 | 15,496 (Direct) | View |
| 2025-08-25 Sale | 2025-08-27 4:56 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 1,000 | $45 | $45,000 | 133,232 (Direct) | View |
| 2025-08-25 Sale | 2025-08-27 4:56 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 1,000 | $45 | $45,000 | 2,208,033 (Indirect Direct) | View |
| 2025-08-22 Sale | 2025-08-26 4:19 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 1,412 | $45 | $63,540 | 134,232 (Direct) | View |
| 2025-08-22 Sale | 2025-08-26 4:18 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 11,780 | $44.49 | $524,092 | 1,246 (Direct) | View |
| 2025-08-22 Sale | 2025-08-26 4:08 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 1,500 | $45 | $67,500 | 2,209,033 (Indirect Direct) | View |
| 2025-08-14 Sale | 2025-08-18 4:31 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Sensenig Bethany Director | 5,369 | $42.25 | $226,840 | 0 (Direct) | View |
| 2025-08-14 Sale | 2025-08-18 4:28 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 7,457 | $42.26 | $315,133 | 46,307 (Direct) | View |
| 2025-08-06 Sale | 2025-08-08 4:40 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 140,000 | $42.02 | $5,883,360 | 2,649,283 (Indirect Direct) | View |
| 2025-02-21 Sale | 2025-02-24 8:20 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 927 | $39.15 | $36,292 | 18,103 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-09-12 Exercise | 2025-09-15 5:39 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Chief Tech. Ops. Officer | 5,000 | $39.4 | 20,496 (Direct) | View |
| 2025-09-12 Exercise | 2025-09-15 5:39 pm | N/A 2028-02-14 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Chief Tech. Ops. Officer | 5,000 | $0 | 20,496 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 4:07 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 1,875 | $0 | 11,855 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 4:05 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 39,320 | $0 | 2,156,903 (Direct) | View |
| 2025-09-08 Exercise | 2025-09-09 4:21 pm | 2018-02-24 2027-02-24 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 8,074 | $0 | 1,274,483 (Direct) | View |
| 2025-09-08 Exercise | 2025-09-09 4:21 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 8,074 | $25.3 | 1,274,483 (Direct) | View |
| 2025-09-05 Exercise | 2025-09-08 4:31 pm | 2018-02-24 2027-02-24 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 73,176 | $0 | 2,286,405 (Direct) | View |
| 2025-09-05 Exercise | 2025-09-08 4:31 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 73,176 | $25.3 | 2,286,405 (Direct) | View |
| 2025-08-27 Exercise | 2025-08-29 4:05 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 55,974 | $12.98 | 2,287,012 (Direct) | View |
| 2025-08-27 Exercise | 2025-08-29 4:05 pm | 2017-03-01 2026-03-01 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 55,974 | $0 | 2,287,012 (Direct) | View |
| 2025-08-25 Exercise | 2025-08-27 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 1,250 | $0 | 13,718 (Direct) | View |
| 2025-08-25 Tax Withholding | 2025-08-27 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 581 | $41.46 | 13,718 (Direct) | View |
| 2025-08-25 Exercise | 2025-08-27 4:59 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 14,000 | $12.98 | 15,496 (Direct) | View |
| 2025-08-25 Exercise | 2025-08-27 4:59 pm | N/A 2026-03-01 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 14,000 | $0 | 15,496 (Direct) | View |
| 2025-08-25 Exercise | 2025-08-27 4:56 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 1,611 | $12.98 | 2,208,033 (Direct) | View |
| 2025-08-25 Exercise | 2025-08-27 4:56 pm | 2017-03-01 2026-03-01 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 1,611 | $0 | 2,208,033 (Direct) | View |
| 2025-08-22 Exercise | 2025-08-26 4:08 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 2,415 | $12.98 | 2,209,033 (Direct) | View |
| 2025-08-22 Exercise | 2025-08-26 4:08 pm | 2017-03-01 2026-03-01 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 2,415 | $0 | 2,209,033 (Direct) | View |
| 2025-08-07 Option Award | 2025-08-08 4:43 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 1,250 | $0 | 14,299 (Direct) | View |
| 2025-08-06 Exercise | 2025-08-08 4:40 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 60,000 | $12.98 | 2,649,283 (Direct) | View |
| 2025-08-06 Exercise | 2025-08-08 4:40 pm | 2017-03-01 2026-03-01 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 201,250 | $0 | 2,649,283 (Direct) | View |
| 2025-08-06 Exercise | 2025-08-08 4:40 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 81,250 | $25.3 | 2,649,283 (Direct) | View |
| 2025-04-02 Other | 2025-04-03 4:27 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 16,850 | $0 | 2,047,983 (Direct) | View |
| 2025-03-10 Tax Withholding | 2025-03-11 4:17 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 16,805 | $32.06 | 2,014,283 (Direct) | View |
| 2025-03-10 Exercise | 2025-03-11 4:17 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 35,000 | $0 | 2,014,283 (Direct) | View |
| 2025-03-10 Tax Withholding | 2025-03-11 4:15 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 2,017 | $32.06 | 12,681 (Direct) | View |
| 2025-03-10 Exercise | 2025-03-11 4:15 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 3,800 | $0 | 12,681 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-07 4:40 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 18,581 | $39.11 | 1,996,088 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-07 4:40 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 38,640 | $0 | 1,996,088 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-07 4:34 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 1,356 | $39.11 | 15,151 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-07 4:34 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 2,625 | $0 | 15,151 (Direct) | View |
| 2025-03-05 Tax Withholding | 2025-03-05 4:23 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 3,193 | $33.05 | 10,898 (Direct) | View |
| 2025-03-05 Tax Withholding | 2025-03-05 4:21 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 910 | $33.05 | 12,704 (Direct) | View |
| 2025-03-05 Tax Withholding | 2025-03-05 4:19 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 1,892 | $33.05 | 13,882 (Direct) | View |
| 2025-03-05 Tax Withholding | 2025-03-05 4:14 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 891 | $33.05 | 9,635 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 4:21 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 35,000 | $0 | 2,011,029 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 4:20 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 3,800 | $0 | 17,891 (Direct) | View |
| 2025-02-26 Exercise | 2025-02-26 5:56 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 5,760 | $0 | 15,774 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-26 5:56 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 2,885 | $39.48 | 15,774 (Direct) | View |
| 2025-02-22 Option Award | 2025-02-24 8:22 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 3,250 | $0 | 21,189 (Direct) | View |
| 2025-02-21 Exercise | 2025-02-24 8:22 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 1,650 | $0 | 21,189 (Direct) | View |
| 2025-02-21 Tax Withholding | 2025-02-24 8:22 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 860 | $39.15 | 21,189 (Direct) | View |
| 2025-02-22 Option Award | 2025-02-24 8:20 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 3,250 | $0 | 18,103 (Direct) | View |
| 2025-02-21 Exercise | 2025-02-24 8:20 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 1,875 | $0 | 18,103 (Direct) | View |
| 2025-02-22 Option Award | 2025-02-24 8:18 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 3,875 | $0 | 21,149 (Direct) | View |
| 2025-02-21 Exercise | 2025-02-24 8:18 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 1,125 | $0 | 21,149 (Direct) | View |
| 2025-02-21 Tax Withholding | 2025-02-24 8:18 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 552 | $39.15 | 21,149 (Direct) | View |
| 2025-02-22 Option Award | 2025-02-24 8:16 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 6,000 | $0 | 28,591 (Direct) | View |
| 2025-02-22 Option Award | 2025-02-24 5:50 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 5,369 | $0 | 53,764 (Direct) | View |
| 2025-02-22 Option Award | 2025-02-24 5:47 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 5,369 | $0 | 135,644 (Direct) | View |
| 2025-02-22 Option Award | 2025-02-24 5:45 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 5,369 | $0 | 18,684 (Direct) | View |
| 2025-02-22 Option Award | 2025-02-24 5:43 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director | 5,369 | $0 | 22,570 (Direct) | View |
| 2025-02-22 Option Award | 2025-02-24 5:41 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Sensenig Bethany Director | 5,369 | $0 | 5,369 (Direct) | View |
| 2025-02-19 Option Award | 2025-02-21 4:57 pm | N/A 2035-02-19 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 24,500 | $0 | 32,951 (Direct) | View |